U.S. Chemicals Stock News

Wondering whether Everpure at US$73.04 still offers value, or if the best gains are already behind it? This article walks through what the current price might be saying about the stock. The share price has been volatile recently, with a decline of 7.5% over the last week sitting against gains of 3.0% over the past month, 5.8% year to date, and 36.2% over the last year, on top of a very large 3 year return and around a 3x move over 5 years. Recent coverage has focused on how Everpure fits...

U-Haul Holding (UHAL) has wrapped up FY 2026 with a mixed set of numbers, as fourth quarter revenue came in at US$1.3 billion and the company reported a loss of US$127.8 million, or basic EPS of US$0.65. The trailing twelve months show total revenue of US$6.0 billion and net income of US$83.1 million, equal to basic EPS of US$0.42. Over the last six reported quarters, revenue has ranged from US$1.2 billion to US$1.7 billion and quarterly basic EPS has swung between a loss of US$0.65 and a...

What recent performance signals for Willis Towers Watson stock Willis Towers Watson (WTW) has seen its stock retreat recently, with the price down 13% over the past month and 17% over the past 3 months, prompting fresh attention from investors. See our latest analysis for Willis Towers Watson. The recent pullback fits into a wider trend, with the share price down 22.76% year to date and the 1-year total shareholder return declining 19.12%, even though the 3-year total shareholder return is...

Recent performance and what is driving interest in Sirius XM Holdings (SIRI) Sirius XM Holdings (SIRI) has drawn fresh attention after a strong share price run, with the stock up about 14% over the past month and roughly 36% in the past 3 months. See our latest analysis for Sirius XM Holdings. That recent momentum builds on a stronger year to date, with a 45.64% share price return since January and a 39.96% total shareholder return over the past year. However, longer term total shareholder...

Alnylam Pharmaceuticals recently expanded its Board of Directors from ten to eleven members and appointed Benjamin F. Cravatt, Ph.D., as a Class III director through 2028, also adding him to its Science and Technology Committee. His appointment brings additional scientific expertise to the boardroom at a time when Alnylam’s RNA interference pipeline and ATTR-CM program are under heightened investor scrutiny following new clinical data and fresh analyst coverage. Next, we’ll examine how...

Sidus Space (NasdaqCM:SIDU) has announced a US$100 million registered direct equity offering that would significantly change its capital base if completed. The company is shifting focus from government contract manufacturing toward scalable, software-defined satellite platforms for commercial and defense customers. Sidus Space recently secured a major defense contract under the Missile Defense Agency’s SHIELD program, supporting its push into defense markets. Sidus Space operates in the...

ICON (ICLR) has wrapped up FY 2025 with fourth quarter revenue of about US$2.2b and a reported basic EPS loss of US$1.44, while trailing twelve month EPS stands at US$2.92 on revenue of roughly US$8.3b. Over recent quarters, revenue has moved from US$2.04b in Q4 FY 2024 to US$2.19b in Q4 FY 2025, with quarterly EPS ranging from US$3.18 in Q4 FY 2024 to US$1.91, US$2.31, US$0.03 and then the latest quarterly loss. This sets up a picture where reported profit has been uneven even as the top...

Why Lear (LEA) is on investor radars today Lear (LEA) has been drawing fresh attention after a period of share price strength, with the stock up over the past month and past 3 months as investors reassess its auto seating and E-Systems business mix. See our latest analysis for Lear. That recent strength fits into a broader upswing, with a 23.88% year to date share price return and a 65.89% 1 year total shareholder return suggesting momentum has been building over both shorter and longer...

On May 22, 2026, Transocean’s shareholders in Zug approved amendments to its Articles of Association, authorizing the issuance of up to 240,801,936 new shares within a capital band and reflecting a revised share capital of US$130,400,968.10 split across 1,304,009,681 registered shares. The company also issued 100,000,000 shares into treasury and moved to dissolve its Finance Committee, signaling a shift toward a more flexible capital management framework concentrated at the board...

Alkermes (NasdaqGS:ALKS) has drawn fresh attention after presenting new clinical and real world data on LYBALVI and ARISTADA at major psychiatry and health economics conferences, highlighting outcomes in schizophrenia, bipolar I disorder, and sleep medicine. See our latest analysis for Alkermes. These research updates land at a time when Alkermes’ share price has moved to US$39.94, with a 30 day share price return of 16.99% and a year to date share price return of 41.33%. The 1 year total...

Freshworks (NasdaqGS:FRSH) released its Global Cost of Complexity Report, highlighting how AI deployment challenges are eroding budgets and delaying projects. The report details productivity loss, higher workloads, and increased error rates tied to complexity in enterprise AI rollouts. These findings position Freshworks as a contributor to the broader conversation on practical AI adoption and return on investment for enterprise customers. Freshworks, trading at around $9.0, has seen its...

Toll Brothers (NYSE:TOL) has announced a series of luxury community launches and model home openings across Washington, South Carolina, Virginia, and Florida over the past week. The updates include new communities in South Carolina and Florida, along with high-end model home unveilings and amenity showcases in Washington and Virginia. This cluster of openings highlights a continued focus on upscale, amenity-rich communities aimed at affluent buyers in multiple regions. For investors...

Amber International Holding (AMBR) opened 2026 with Q1 revenue of US$10.0 million and a net loss from continuing operations of US$3.7 million, while the trailing 12 month figures show revenue of US$61.6 million and net income from continuing operations close to breakeven at US$0.02 million. Over recent quarters the company has seen revenue move from US$4.8 million in Q4 2024 to between US$14.9 million and US$21.0 million across 2025, with basic EPS ranging from a loss of US$0.38 to a gain of...

DouYu International Holdings (NasdaqGS:DOYU) opened 2026 with Q1 revenue of C¥821.8 million and net income of C¥27.4 million, translating into basic EPS of C¥0.0009, while the trailing twelve months show revenue of C¥3.7 billion and net income of C¥77.9 million with EPS of C¥2.58. The company has seen quarterly revenue move from C¥947.1 million in Q1 2025 to C¥821.8 million in Q1 2026, while basic EPS shifted from a loss of C¥2.64 in Q1 2025 to a small profit in the latest quarter. This sets...

X Financial (XYF) opened Q1 2026 with revenue of C¥1,176.1 million and basic EPS of C¥0.97, against a backdrop where the trailing 12 months show C¥6.9 billion in revenue and basic EPS of C¥26.17. The company has seen quarterly revenue move from C¥1,937.5 million and basic EPS of C¥10.90 in Q1 2025 to C¥1,176.1 million and C¥0.97 in Q1 2026. Trailing net income over the latest 12 months was C¥1,044.37 million, setting up a story where compressed margins and prior one off impacts sit alongside...

Ouster (OUST) is back on investor radars after its digital lidar was selected for ARGUS Interception’s A1-Falke net-based interceptor drones, a move that ties the company more closely to counter-drone and public safety applications. See our latest analysis for Ouster. Ouster’s recent ARGUS agreement comes on the heels of partnerships with Gecko Robotics and Fujifilm around its Rev8 digital lidar. This drumbeat of news has coincided with a 30 day share price return of 62% and a one year total...

Earlier in 2026, Serve Robotics Inc. reported first-quarter revenue of US$3.0 million and acquired Diligent Robotics, extending its autonomous delivery and healthcare robotics footprint to 44 cities across 14 states while reiterating full-year 2026 revenue guidance of about US$26.0 million. This combination of strong recent revenue growth and a move into healthcare robotics signals a broader business scope and evolving revenue mix for Serve Robotics. Next, we’ll assess how Serve Robotics’...

American Superconductor (AMSC) closed FY 2026 with Q4 revenue of US$86.4 million and basic EPS of US$0.10, alongside trailing 12 month revenue of US$299.2 million and basic EPS of US$3.12 that reflect the sharp earnings improvement reported over the past year. Over recent quarters the company has seen revenue move from US$66.7 million and basic EPS of US$0.03 in Q4 FY 2025 to US$72.4 million and US$0.17 in Q1 FY 2026, US$65.9 million and US$0.11 in Q2, US$74.5 million and US$2.68 in Q3, and...

Xunlei (NasdaqGS:XNET) has just posted a mixed Q1 2026 update, with revenue of US$98.1 million and a reported loss of US$192.4 million on a net income basis, alongside a trailing twelve month earnings growth rate that is very large compared to the prior year. Over the last five reported quarters, the company has seen revenue range from US$83.9 million in Q4 2024 up to US$142.5 million in Q4 2025, while quarterly EPS has swung between a loss of US$3.64 and a gain of US$11.65. This sets the...

Skyworks Solutions (NasdaqGS:SWKS) is pursuing a pending merger with Qorvo that would combine two major RF and connectivity suppliers. The merger process includes exchange offers and consent solicitations for Qorvo's senior notes, aimed at reshaping the combined group's debt structure. Separately, Skyworks has secured a multi generational design win with a leading Android OEM, with revenue potential expected through 2030. Skyworks Solutions, a key supplier of RF chips and connectivity...

In May 2026, Sarah Cannon Research Institute announced a collaboration with Pfizer to accelerate development of Pfizer’s oncology portfolio using SCRI’s Accelero clinical trial model, while Pfizer also reported strong Phase 2 data for its 25-valent pneumococcal vaccine candidate in infants compared with Prevnar 20 and moved it into pivotal Phase 3 trials. A particularly important insight is 25vPnC’s much stronger immune response against serotype 3, a persistent driver of serious pediatric...

Wondering whether Align Technology at US$173.25 is starting to look like value, or if the stock still carries more hype than fundamentals. The share price is up 6.3% over the last 7 days and 11.0% year to date, but is still down 2.3% over 30 days and has declined 5.4% over 1 year, 41.7% over 3 years and 69.4% over 5 years. These swings have kept Align on many investors' watchlists, as the company continues to be a reference point in clear aligner dentistry and digital orthodontics. Recent...

Snowflake (SNOW) has opened Q1 2027 with revenue of US$1.4b, a basic EPS loss of US$0.86, and net income excluding extraordinary items showing a loss of US$295.6m, setting a clear backdrop for how the business is trading off growth against profitability. Over the last several quarters, the company has seen revenue move from US$1.0b in Q1 2026 to US$1.4b in Q1 2027, while quarterly basic EPS losses have ranged between US$0.86 and US$1.29 over the same stretch. For investors, the key question...

Dollar General (NYSE:DG) shareholders are preparing to vote on a proposed board-level human rights policy at the upcoming annual meeting. The proposal follows pressure from institutional investors and faith-based groups for clearer oversight of workplace and community impacts. Separately, the company has outlined a CEO succession plan, with a leadership transition targeted for 2027. For investors watching NYSE:DG, these governance developments come as the stock trades around $109.9, with...